← Leaderboards
Robert John North
Trudeau Institute, Inc.
$4,902,398
Attributed
$4,902,398
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $739.3K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$4,902,398 · 4
By mechanism
R01$4,202,398 · 3
R21$700,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Trudeau Institute, Inc.
Same institution · by research overlap
- David L Woodland$14,525,718
- Dyana K. Dalton$1,744,828
- Richard W Dutton$6,389,519
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisLaboratory MouseCytokineHost Organism InteractionVirulenceHelper T LymphocyteRnase Protection AssayCellular ImmunityGenetic StrainEnzyme Linked Immunosorbent AssayMacrophageAntitubercular AgentsTuberculosisLungGene ExpressionHistopathologyPathologic ProcessBactericidal ImmunityMicroorganism ImmunologyChemokineIntravenous AdministrationImmunocytochemistryLatent Bacterial DiseaseCd4 Molecule
Grant awards (14)
Anti-tuberculosis vaccination: The role of macrophages$375,067
R01 · FY2008 · AI · contact PI
Anti-tuberculosis vaccination: The role of macrophages$382,331
R01 · FY2007 · AI · contact PI
Anti-tuberculosis vaccination: The role of macrophages$393,750
R01 · FY2006 · AI · contact PI
IMMUNOLOGIC CONSEQUENCES OF M. TUBERCULOSIS VIRULENCE$389,250
R01 · FY2005 · AI
M. bovis as a potentially more virulent MDR pathogen$350,000
R21 · FY2005 · AI
IMMUNOLOGIC CONSEQUENCES OF M. TUBERCULOSIS VIRULENCE$389,250
R01 · FY2004 · AI
M. bovis as a potentially more virulent MDR pathogen$350,000
R21 · FY2004 · AI
IMMUNOLOGIC CONSEQUENCES OF M. TUBERCULOSIS VIRULENCE$389,250
R01 · FY2003 · AI
HOST-PATHOGEN DETERMINANTS OF MOUSE TUBERCULOSIS LATENCY$302,750
R01 · FY2003 · HL
IMMUNOLOGIC CONSEQUENCES OF M. TUBERCULOSIS VIRULENCE$389,250
R01 · FY2002 · AI
HOST-PATHOGEN DETERMINANTS OF MOUSE TUBERCULOSIS LATENCY$302,750
R01 · FY2002 · HL
IMMUNOLOGIC CONSEQUENCES OF M. TUBERCULOSIS VIRULENCE$389,250
R01 · FY2001 · AI
HOST-PATHOGEN DETERMINANTS OF MOUSE TUBERCULOSIS LATENCY$259,500
R01 · FY2001 · HL
HOST-PATHOGEN DETERMINANTS OF MOUSE TUBERCULOSIS LATENCY$240,000
R01 · FY2000 · HL